Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
NCT05145127
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
245
Enrollment
INDUSTRY
Sponsor class
Conditions
Hemophilia A
Hemophilia B
Interventions
DRUG:
PF-06741086
Sponsor
Pfizer